GSK Ordered to Pay $3M in Generic Paxil Suicide Suit

April 21, 2017, 6:56 PM UTC

GlaxoSmithKline LLC was ordered to pay $3 million to the widow of a Chicago attorney who committed suicide days after starting a generic equivalent of the company’s antidepressant Paxil (Dolin v. SmithKlineBeecham Corp., N.D. Ill., No. 12-6403, verdict 4/20/17).

A jury in the U.S. District Court for the Northern District of Illinois handed down its verdict April 20. Trial began March 14.

Only one other Paxil suicide case has been tried, and few others are pending, a GSK representative said earlier.

Stewart Dolin, a partner at the law firm Reed Smith, began taking generic Paxil July 10, 2010, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.